Spectral Diagnostics Return on Tangible Equity 2010-2025 | EDTXF
Current and historical return on tangible equity values for Spectral Diagnostics (EDTXF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Spectral Diagnostics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.02B | $-0.03B | 78.16% |
| 2024-12-31 | $-0.01B | $-0.02B | 58.67% |
| 2024-09-30 | $-0.02B | $-0.02B | 107.46% |
| 2024-06-30 | $-0.01B | $-0.02B | 107.69% |
| 2024-03-31 | $-0.01B | $-0.02B | 136.59% |
| 2023-12-31 | $-0.01B | $-0.01B | 165.52% |
| 2023-09-30 | $-0.01B | $-0.01B | 189.47% |
| 2023-06-30 | $-0.01B | $-0.01B | 228.57% |
| 2023-03-31 | $-0.01B | $0.00B | 311.11% |
| 2022-12-31 | $-0.01B | $0.00B | 800.00% |
| 2022-09-30 | $-0.01B | $0.00B | -3200.00% |
| 2022-06-30 | $-0.01B | $0.00B | -355.56% |
| 2022-03-31 | $-0.01B | $0.00B | -355.56% |
| 2021-12-31 | $-0.01B | $0.00B | -400.00% |
| 2021-09-30 | $0.75B | $0.01B | 100133.33% |
| 2021-06-30 | $0.75B | $0.00B | -300800.00% |
| 2021-03-31 | $-0.01B | $0.00B | -1000.00% |
| 2020-12-31 | $-0.01B | $0.00B | -1400.00% |
| 2020-09-30 | $-0.76B | $0.00B | -61120.00% |
| 2020-06-30 | $-0.76B | $0.00B | -43657.14% |
| 2020-03-31 | $-0.01B | $0.00B | -300.00% |
| 2019-12-31 | $0.00B | $0.00B | -133.33% |
| 2019-09-30 | $0.00B | $0.00B | -80.00% |
| 2019-06-30 | $0.00B | $0.00B | -75.00% |
| 2019-03-31 | $0.00B | $0.00B | -66.67% |
| 2018-12-31 | $0.00B | $0.01B | -75.00% |
| 2018-09-30 | $0.00B | $0.00B | -123.08% |
| 2018-06-30 | $0.00B | $0.01B | -145.45% |
| 2018-03-31 | $0.00B | $0.00B | -177.78% |
| 2017-12-31 | $0.00B | $0.00B | -145.45% |
| 2017-09-30 | $0.00B | $0.00B | -123.08% |
| 2017-06-30 | $-0.01B | $0.00B | -125.00% |
| 2017-03-31 | $-0.01B | $0.00B | -140.00% |
| 2016-12-31 | $-0.01B | $0.00B | -128.00% |
| 2016-09-30 | $-0.01B | $0.01B | -144.00% |
| 2016-06-30 | $-0.01B | $0.01B | -138.46% |
| 2016-03-31 | $-0.01B | $0.01B | -118.52% |
| 2015-12-31 | $-0.01B | $0.00B | -139.13% |
| 2015-09-30 | $-0.01B | $0.01B | -118.52% |
| 2015-06-30 | $-0.01B | $0.01B | -103.23% |
| 2015-03-31 | $-0.01B | $0.01B | -139.13% |
| 2014-12-31 | $-0.01B | $0.01B | -180.00% |
| 2014-09-30 | $-0.01B | $0.01B | -235.29% |
| 2014-06-30 | $-0.01B | $0.00B | -266.67% |
| 2014-03-31 | $-0.01B | $0.00B | -176.00% |
| 2013-12-31 | $-0.01B | $0.01B | -129.03% |
| 2013-09-30 | $-0.01B | $0.01B | -100.00% |
| 2013-06-30 | $-0.01B | $0.01B | -90.00% |
| 2013-03-31 | $-0.01B | $0.01B | -72.73% |
| 2012-12-31 | $-0.01B | $0.01B | -61.54% |
| 2012-09-30 | $-0.01B | $0.01B | -52.46% |
| 2012-06-30 | $-0.01B | $0.01B | -45.71% |
| 2012-03-31 | $-0.01B | $0.02B | -46.38% |
| 2011-12-31 | $-0.01B | $0.02B | -47.76% |
| 2011-09-30 | $-0.01B | $0.02B | -50.79% |
| 2011-06-30 | $-0.01B | $0.01B | -49.12% |
| 2011-03-31 | $-0.01B | $0.01B | -40.00% |
| 2010-12-31 | $-0.01B | $0.02B | -37.50% |
| 2010-09-30 | $-0.01B | $0.02B | -40.00% |
| 2010-06-30 | $0.00B | $0.02B | -43.24% |
| 2010-03-31 | $0.00B | $0.02B | -69.57% |
| 2009-12-31 | $0.00B | $0.00B | -114.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.171B | $0.002B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.650B | 83.94 |
| Thermo Fisher Scientific (TMO) | United States | $158.057B | 19.12 |
| Edwards Lifesciences (EW) | United States | $44.986B | 29.50 |
| IDEXX Laboratories (IDXX) | United States | $43.875B | 50.42 |
| Alcon (ALC) | Switzerland | $42.814B | 28.93 |
| DexCom (DXCM) | United States | $32.521B | 50.27 |
| IQVIA Holdings (IQV) | United States | $28.104B | 15.74 |
| Mettler-Toledo (MTD) | United States | $24.701B | 29.38 |
| STERIS (STE) | Ireland | $22.952B | 25.28 |
| Waters (WAT) | United States | $20.634B | 29.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.292B | 0.00 |
| Hologic (HOLX) | United States | $14.345B | 15.59 |
| Sysmex ADR (SSMXY) | Japan | $10.437B | 29.61 |
| Penumbra (PEN) | United States | $9.618B | 75.49 |
| Masimo (MASI) | United States | $8.808B | 32.49 |
| Globus Medical (GMED) | United States | $7.577B | 18.06 |
| Glaukos (GKOS) | United States | $5.797B | 0.00 |
| Teleflex (TFX) | United States | $5.156B | 8.51 |
| TransMedics (TMDX) | United States | $4.234B | 92.03 |
| Integer Holdings (ITGR) | United States | $4.083B | 21.39 |
| PROCEPT BioRobotics (PRCT) | United States | $3.152B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.485B | 14.80 |
| Veracyte (VCYT) | United States | $2.063B | 28.94 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Nihon Kohden (NHNKY) | Japan | $1.867B | 21.41 |
| Alphatec Holdings (ATEC) | United States | $1.598B | 0.00 |
| Artivion (AORT) | United States | $1.293B | 121.16 |
| Tandem Diabetes Care (TNDM) | United States | $1.082B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.064B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.991B | 5.27 |
| SiBone (SIBN) | United States | $0.768B | 0.00 |
| IRadimed (IRMD) | United States | $0.750B | 38.08 |
| Beta Bionics (BBNX) | United States | $0.581B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.547B | 8.51 |
| AxoGen (AXGN) | United States | $0.517B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.516B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| RxSight (RXST) | United States | $0.505B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.441B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.434B | 11.56 |
| Delcath Systems (DCTH) | United States | $0.426B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.420B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.380B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.373B | 0.00 |
| NeuroPace (NPCE) | United States | $0.335B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.315B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.279B | 0.00 |
| 908 Devices (MASS) | United States | $0.230B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.90 |
| Neuronetics (STIM) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.195B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 45.90 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.33 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.019B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.97 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |